BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22719219)

  • 1. Reduction in Tcf7l2 expression decreases diabetic susceptibility in mice.
    Yang H; Li Q; Lee JH; Shu Y
    Int J Biol Sci; 2012; 8(6):791-801. PubMed ID: 22719219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis.
    Shao W; Wang D; Chiang YT; Ip W; Zhu L; Xu F; Columbus J; Belsham DD; Irwin DM; Zhang H; Wen X; Wang Q; Jin T
    Diabetes; 2013 Mar; 62(3):789-800. PubMed ID: 22966074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A High-Throughput Genome-Integrated Assay Reveals Spatial Dependencies Governing Tcf7l2 Binding.
    Szczesnik T; Chu L; Ho JWK; Sherwood RI
    Cell Syst; 2020 Sep; 11(3):315-327.e5. PubMed ID: 32910904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand.
    Boj SF; van Es JH; Huch M; Li VS; José A; Hatzis P; Mokry M; Haegebarth A; van den Born M; Chambon P; Voshol P; Dor Y; Cuppen E; Fillat C; Clevers H
    Cell; 2012 Dec; 151(7):1595-607. PubMed ID: 23260145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of pancreatic lipid content and gene variants (TCF7L2, WFS1 and 11BHSD1) on B-cell function in Middle Aged Women in a Post Hoc Analysis.
    Nádasdi Á; Gál V; Masszi T; Patócs A; Igaz P; Somogyi A; Firneisz G
    Diabetol Metab Syndr; 2022 Jul; 14(1):106. PubMed ID: 35897035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazole-Based Inhibitors of the Wnt/β-Catenin Signaling Pathway Improve Glucose and Lipid Metabolisms in Diet-Induced Obese Mice.
    Obianom ON; Ai Y; Li Y; Yang W; Guo D; Yang H; Sakamuru S; Xia M; Xue F; Shu Y
    J Med Chem; 2019 Jan; 62(2):727-741. PubMed ID: 30605343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?
    Adams JD; Vella A
    Metab Syndr Relat Disord; 2018 Oct; 16(8):383-389. PubMed ID: 29993315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.
    Li R; Ou J; Li L; Yang Y; Zhao J; Wu R
    Front Pharmacol; 2018; 9():379. PubMed ID: 29713286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses.
    Baranski TJ; Kraja AT; Fink JL; Feitosa M; Lenzini PA; Borecki IB; Liu CT; Cupples LA; North KE; Province MA
    PLoS Genet; 2018 Apr; 14(4):e1007222. PubMed ID: 29608557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.
    Chen X; Ayala I; Shannon C; Fourcaudot M; Acharya NK; Jenkinson CP; Heikkinen S; Norton L
    Diabetes; 2018 Apr; 67(4):554-568. PubMed ID: 29317436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare intronic variants of TCF7L2 arising by selective sweeps in an indigenous population from Mexico.
    Acosta JL; Hernández-Mondragón AC; Correa-Acosta LC; Cazañas-Padilla SN; Chávez-Florencio B; Ramírez-Vega EY; Monge-Cázares T; Aguilar-Salinas CA; Tusié-Luna T; Del Bosque-Plata L
    BMC Genet; 2016 May; 17(1):68. PubMed ID: 27230431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice.
    Bailey KA; Savic D; Zielinski M; Park SY; Wang LJ; Witkowski P; Brady M; Hara M; Bell GI; Nobrega MA
    Hum Mol Genet; 2015 Mar; 24(6):1646-54. PubMed ID: 25398947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCF7L2 is a master regulator of insulin production and processing.
    Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
    Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
    Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
    Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of GWAS-identified type 2 diabetes genes.
    da Silva Xavier G; Bellomo EA; McGinty JA; French PM; Rutter GA
    J Diabetes Res; 2013; 2013():906590. PubMed ID: 23710470
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.